Abstract: The present invention relates to the use of new and known dithiine derivatives for controlling unwanted microorganisms, more particularly phytopathogenic fungi, in crop protection, in the household and hygiene sector and in the protection of materials, and also to new dithiine derivatives, to processes for preparing them, to their use, and to crop protection compositions comprising these new dithiine derivatives.
Type:
Grant
Filed:
November 18, 2013
Date of Patent:
March 29, 2016
Assignee:
Bayer Intellectual Property GmbH
Inventors:
Thomas Seitz, Jurgen Benting, Ulrike Wachendorff-Neumann
Abstract: The invention provides methods to determine the ascorbate profile value for plant lines and to use these values in the identification of the better performing plant lines, without having to resort to extensive field trialing.
Abstract: The present invention relates to novel mixtures, to processes for preparing these mixtures, to compositions comprising these mixtures, and to the use thereof as biologically active compounds, especially for control of harmful microorganisms or pests in crop protection and in the protection of materials and as plant growth regulators.
Abstract: The invention relates to fiber-composite components, obtained for example by impregnating fibers with a reaction resin mixture of polyisocyanates, polyepoxides, polyols, latent catalysts and optionally additives. The invention also relates to a method for producing said components.
Type:
Grant
Filed:
August 16, 2013
Date of Patent:
March 22, 2016
Assignee:
Bayer MaterialScience AG
Inventors:
Florian Hupka, Marcel Schornstein, Dirk Wegener, Harald Rasselnberg
Abstract: An apparatus for the detection of extravasation of an injection fluid infused into a tissue during an imaging procedure is disclosed. The apparatus includes at least a first source of energy to supply an X-ray or gamma ray imaging energy to tissue in the vicinity of a site and at least a first sensor to measure an energy signal resulting from the energy supplied to the tissue by the first imaging energy source, and circuitry configured to compare the energy signal detected by the first sensor to a baseline measurement and provide an alert that extravasation is occurring.
Type:
Grant
Filed:
March 20, 2006
Date of Patent:
March 22, 2016
Assignee:
Bayer HealthCare LLC
Inventors:
James E. Dvorsky, Chad E. Bouton, Alan D. Hirschman
Abstract: The present invention relates to amino-substituted imidazopyridazine compounds of general formula (I); in which A, R1, R2, R3, R4, R5 and n are as defined in the claims, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative and/or angiogenesis disorder, as a sole agent or in combination with other active ingredients.
Type:
Grant
Filed:
March 27, 2013
Date of Patent:
March 22, 2016
Assignee:
BAYER PHARMA AKTIENGESELLSCHAFT
Inventors:
Knut Eis, Florian Puehler, Ludwig Zorn, Volker Schulze, Detlev Sülzle, Philip Lienau, Andrea Hägebarth, Kirstin Petersen, Ulf Bömer
Abstract: The application relates to polymeric antistatic agents for use in polymer molding compositions, as well as molding compositions containing these antistatic agents, the antistatic agents having good compounding properties and being inexpensive to produce, wherein the antistatic agent is an antistatic agent of the general formula (I) having a polymeric cationic polyelectrolyte constituent produced from diallyldialkylammonium compounds and an anionic counterion A?, in which R1 is uniformly or mutually independently C1-C18 alkyl, A? is an acid anion, and n is a whole number from 10 to 1000.
Abstract: The present invention relates to a method of producing aromatic amines by hydrogenation of aromatic nitro compounds. This method provides a reactor containing a hydrogenation catalyst; supplies aromatic nitro compounds and hydrogen to the reactor and contacts them with a hydrogenation catalyst, in which the hydrogen which is supplied to the reactor is by a compressor and the compressor contains an operating fluid which at least partially contacts the hydrogen; and regenerates the hydrogenation catalyst by heating and contacting it with oxygen. Particular operating liquids are subsequently exchanged.
Type:
Grant
Filed:
April 12, 2013
Date of Patent:
March 22, 2016
Assignee:
Bayer MaterialScience AG
Inventors:
Michael Merkel, Thomas Knauf, Cliff Andre Peters, Thorsten Schmidt
Abstract: Polymer compositions with improved lacquer adhesion comprising A) 30 to 80 parts by wt. of at least one polymer chosen from the group of aromatic polycarbonates and aromatic polyester carbonates, B) 2 to 40 parts by wt. of at least one rubber-free and/or rubber-modified vinyl (co)polymer, the rubber-modified vinyl (co)polymers being prepared in the bulk, solution or suspension polymerization process, C) 0.5 to 20.0 parts by wt. of at least one rubber-modified vinyl (co)polymer prepared in the emulsion polymerization process, D) 2 to 16 parts by wt. of at least one polymer, E) 0 to 35 parts by wt. of at least one inorganic filler or reinforcing substance, F) 0.01 to 20.0 parts by wt. of at least one polymer additive, wherein the sum of the parts by weight of components A+B+C+D+E+F in the composition is 100.
Abstract: Urethanes are prepared by oxidative carbonylation of at least one amino compound in the presence of carbon monoxide, oxygen and organic, at least one hydroxyl-group-carrying compound. The carbonylation is carried out in the absence of halogen-containing promoters. The carbonylation is also carried out in the presence of a metal complex catalyst which contains neutral bidentate N-chelate ligands of the (N˜N) type, two monoanionic N,O-chelate ligands of the general type (N˜O)? or tetradentate dianionic chelate ligands (O˜N˜N˜O)2?.
Type:
Grant
Filed:
January 28, 2009
Date of Patent:
March 15, 2016
Assignee:
Bayer MaterialScience AG
Inventors:
Andreas Jacob, Stefan Wershofen, Stephan Klein, Jörg Sundermeyer, Fuming Mei
Abstract: The invention relates to an adiabatic process for producing nitrobenzene by nitrating benzene with sulphuric acid mixtures and nitric acid mixtures using a stoichiometric excess of benzene and reusing non-reacted benzene, the content of the aliphatic organic compounds in the feed benzene being limited, by the targeted evacuation of aliphatic organic compounds to at least one step in the process, to a content of less than 1.5 mass-%, in relation to the total amount of feed benzene.
Type:
Grant
Filed:
July 23, 2013
Date of Patent:
March 15, 2016
Assignee:
Bayer MaterialScience AG
Inventors:
Thomas Knauf, Alexandre Racoes, Wolfgang Dohmen, Antoni Mairata
Abstract: A process for the preparation of a solid, orally administrable pharmaceutical composition, comprising 5-chloro-N-({(5)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide comprising preparing granules in hydrophilized form using fluidized bed granulation for moist granulation, adding additives, compressing to form a tablet, and coating the tablet.
Abstract: The present invention relates to substituted imidazopyrazine compounds of general formula (I): in which R1, R2, R3, R4 and R5 are as defined in the claims, to methods of and intermediates for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative and/or angiogenesis disorder, as a sole agent or in combination with other active ingredients.
Type:
Grant
Filed:
December 13, 2011
Date of Patent:
March 15, 2016
Assignee:
Bayer Intellectual Property GmbH
Inventors:
Marcus Koppitz, Ulrich Klar, Rolf Jautelat, Dirk Kosemund, Rolf Bohlmann, Benjamin Bader, Philip Lienau, Gerhard Siemeister
Abstract: The present invention relates to heterocyclyl aminoimidazopyridazine compounds of general formula (I): in which A, R1, R2, R3 and R4 are as defined in the claims, to methods of preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of a hyper-proliferative and/or angiogenesis disorder, as a sole agent or in combination with other active ingredients.
Type:
Grant
Filed:
June 21, 2012
Date of Patent:
March 15, 2016
Assignee:
BAYER INTELLECTUAL PROPERTY GMBH
Inventors:
Knut Eis, Florian Pühler, Ludwig Zorn, Arne Scholz, Philip Lienau, Mark Jean Gnoth, Ulf Bömer, Judith Günther, Jörg Fanghänel, Daniel Korr
Abstract: The present invention provides a process for the preparation of polyols based on fatty acid esters and starter compounds having Zerewitinoff-active hydrogen atoms and the use thereof for the preparation of polyurethane materials.
Type:
Grant
Filed:
March 5, 2007
Date of Patent:
March 15, 2016
Assignees:
Bayer MaterialScience LLC, Bayer MaterialScience AG
Inventors:
Klaus Lorenz, Reinhard Albers, Frank Otto, Ulrich Leyrer, Don S. Wardius, Keith J. Headley
Abstract: The present invention relates to a process for the preparation of a solid, orally administrable pharmaceutical composition, comprising 5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide in hydrophilized form, and its use for the prophylaxis and/or treatment of diseases.
Abstract: The present invention provides a continuous process for the production of nitrobenzene by nitration of benzene with mixtures of sulfuric and nitric acid using a stoichiometric excess of benzene, in which the content of aliphatic organic compounds in the feed benzene during the start-up period of the production plant is always maintained at less than 1.5 wt. %, based on the total mass of the feed benzene. This is achieved either by mixing the feed benzene comprising recycled unreacted benzene (recycled benzene) and benzene newly supplied to the reaction (fresh benzene) in appropriate quantitative ratios during the start-up period, depending on the purity of the two streams, or by completely omitting the recycling of unreacted benzene during the start-up period, i.e. the feed benzene consists only of benzene newly supplied to the reaction.